Several published case series have identified Ephrin type-B receptor 4 (EPHB4) dominant variants in Capillary Malformation—Arteriovenous Malformation 2 (CM-AVM 2), especially in people with a vein of Galen aneurysmal malformation (VGAM) (1–3). Here, EPHB4 is linked to capillary malformation.